Skip to main content
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1974 May;50(583):270–275.

The effect of Verapamil on the cardiac conduction system in man

P R Roy, R A J Spurrell, E Sowton
PMCID: PMC2495541

Abstract

Using His bundle electrograms the effect of Verapamil on the specialized conduction system in eleven patients was studied during routine cardiac catheterization.

In five patients, the absolute and relative refractory periods of the A-V node, and retrograde conduction through the A-V node was studied using programmed electrical stimulation techniques.

Verapamil caused prolongation of anterograde and retrograde A-V nodal conduction times. The effect on anterograde conduction was only partly reversible with Atropine. No significant effect on the remainder of the conduction system was observed.

It is concluded that Verapamil has a direct effect on A-V nodal conduction independent of any vagotonic effect.

Full text

PDF
270

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Damato A. N., Lau S. H., Helfant R. H., Stein E., Berkowitz W. D., Cohen S. I. Study of atrioventricular conduction in man using electrode catheter recordings of His bundle activity. Circulation. 1969 Mar;39(3):287–296. doi: 10.1161/01.cir.39.3.287. [DOI] [PubMed] [Google Scholar]
  2. Fleckenstein A., Kammermeier H., Döring H. J., Freund H. J. Zum Wirkungsmechanismus neuartiger Koronardilatatoren mit gleichzeitig Sauerstoff-einsparenden Myokard-Effekten, Prenylamin und Iproveratril. 1. Z Kreislaufforsch. 1967 Jul;56(7):716–744. [PubMed] [Google Scholar]
  3. Garvey H. L. The mechanism of action of verapamil on the sinus and AV nodes. Eur J Pharmacol. 1969 Nov;8(2):159–166. doi: 10.1016/0014-2999(69)90071-5. [DOI] [PubMed] [Google Scholar]
  4. Goldreyer B. N., Bigger J. T., Jr Site of reentry in paroxysmal supraventricular tachycardia in man. Circulation. 1971 Jan;43(1):15–26. doi: 10.1161/01.cir.43.1.15. [DOI] [PubMed] [Google Scholar]
  5. Goldreyer B. N., Damato A. N. The essential role of atrioventricular conduction delay in the initiation of paroxysmal supraventricular tachycardia. Circulation. 1971 May;43(5):679–687. doi: 10.1161/01.cir.43.5.679. [DOI] [PubMed] [Google Scholar]
  6. Narula O. S., Scherlag B. J., Samet P. Pervenous pacing of the specialized conducting system in man. His bundle and A-V nodal stimulation. Circulation. 1970 Jan;41(1):77–87. doi: 10.1161/01.cir.41.1.77. [DOI] [PubMed] [Google Scholar]
  7. Nayler W. G., Szeto J. Effect of verapamil on contractility, oxygen utilization, and calcium exchangeability in mammalian heart muscle. Cardiovasc Res. 1972 Mar;6(2):120–128. doi: 10.1093/cvr/6.2.120. [DOI] [PubMed] [Google Scholar]
  8. Oram S., Catley P. F., Livesley B., Kidner P. H. An antidysrhythmic agent. Br Med J. 1971 Oct 9;4(5779):113–113. doi: 10.1136/bmj.4.5779.113-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Schamroth L., Krikler D. M., Garrett C. Immediate effects of intravenous verapamil in cardiac arrhythmias. Br Med J. 1972 Mar 11;1(5801):660–662. doi: 10.1136/bmj.1.5801.660. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Scherlac B. J., Samet P., Helfant R. H. His bundle electrogram. A critical appraisal of its uses and limitations. Circulation. 1972 Sep;46(3):601–613. doi: 10.1161/01.cir.46.3.601. [DOI] [PubMed] [Google Scholar]
  11. Scherlag B. J., Lau S. H., Helfant R. H., Berkowitz W. D., Stein E., Damato A. N. Catheter technique for recording His bundle activity in man. Circulation. 1969 Jan;39(1):13–18. doi: 10.1161/01.cir.39.1.13. [DOI] [PubMed] [Google Scholar]
  12. Singh B. N. A fourth class of anti-dysrhythmic action? Effect of verapamil on ouabain toxicity, on atrial and ventricular intracellular potentials, and on other features of cardiac function. Cardiovasc Res. 1972 Mar;6(2):109–119. doi: 10.1093/cvr/6.2.109. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES